Frankfurt - Delayed Quote EUR
BioSenic S.A. (BT1.F)
At close: October 25 at 8:00 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-3,470.0000
-3,470.0000
-1,910.0000
-1,067.0000
-16,082.0000
--
Investing Cash Flow
6.0000
6.0000
1,952.0000
--
11,908.0000
--
Financing Cash Flow
1,735.0000
1,735.0000
1,045.0000
1,170.0000
10,188.0000
--
End Cash Position
117.0000
117.0000
1,846.0000
759.0000
14,648.0000
--
Capital Expenditure
--
--
-5.0000
-207.0000
-93.0000
-310.0000
Issuance of Capital Stock
1,500.0000
1,500.0000
500.0000
--
11,783.0000
--
Issuance of Debt
1,000.0000
1,000.0000
1,026.0000
1,391.0000
10,298.0000
--
Repayment of Debt
-413.0000
-413.0000
-424.0000
-181.0000
-6,611.0000
--
Free Cash Flow
-3,470.0000
-3,470.0000
-1,915.0000
-1,067.0000
-16,175.0000
--
12/31/2019 - 2/11/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MWG0.SG InMed Pharmaceuticals Inc
0.2980
+12.88%
2JQ.DU Gritstone Bio Inc
0.0337
0.00%
MWG0.BE InMed Pharmaceuticals Inc
0.2795
+5.47%
MWG0.F InMed Pharmaceuticals Inc.
0.2485
-2.74%
LMQ.BE Oxford BioDynamics PLC
0.0155
0.00%
2JQ.SG Gritstone bio, Inc.
0.0294
0.00%
1IY0.MU MONOPAR THERAP. NEW
4.8400
0.00%
2JQ.BE Gritstone Bio Inc
0.0299
0.00%
2DE0.MU Genprex Inc
0.5400
0.00%
AREC.L Arecor Therapeutics plc
77.00
+3.36%